1. Home
  2. UNP vs AZN Comparison

UNP vs AZN Comparison

Compare UNP & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Union Pacific Corporation

UNP

Union Pacific Corporation

HOLD

Current Price

$272.32

Market Cap

157.1B

Sector

Industrials

ML Signal

HOLD

Logo AstraZeneca PLC

AZN

AstraZeneca PLC

HOLD

Current Price

$185.45

Market Cap

316.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UNP
AZN
Founded
1862
1992
Country
United States
United Kingdom
Employees
N/A
96100
Industry
Railroads
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
157.1B
316.4B
IPO Year
2005
N/A

Fundamental Metrics

Financial Performance
Metric
UNP
AZN
Price
$272.32
$185.45
Analyst Decision
Buy
Strong Buy
Analyst Count
23
1
Target Price
$275.55
N/A
AVG Volume (30 Days)
2.7M
1.7M
Earning Date
04-23-2026
04-29-2026
Dividend Yield
2.08%
1.73%
EPS Growth
8.03
N/A
EPS
2.87
N/A
Revenue
$19,533,000,000.00
N/A
Revenue This Year
$5.57
$10.34
Revenue Next Year
$4.29
$6.43
P/E Ratio
$91.74
$31.91
Revenue Growth
N/A
N/A
52 Week Low
$214.32
$68.62
52 Week High
$279.70
$212.71

Technical Indicators

Market Signals
Indicator
UNP
AZN
Relative Strength Index (RSI) 57.45 49.81
Support Level $218.81 $180.98
Resistance Level $272.40 $191.50
Average True Range (ATR) 6.88 3.00
MACD -0.72 -0.05
Stochastic Oscillator 64.26 61.27

Price Performance

Historical Comparison
UNP
AZN

About UNP Union Pacific Corporation

Omaha, Nebraska-based Union Pacific is the largest public railroad in North America. Operating on more than 30,000 miles of track in the western two-thirds of the US, Union Pacific generated $24.5 billion of revenue in 2025 by hauling coal, industrial products, intermodal containers, agricultural goods, chemicals, fertilizers, and automotive goods. Union Pacific owns about one-fourth of Mexican railroad Ferromex and historically derives roughly 10% of its revenue hauling freight to and from Mexico.

About AZN AstraZeneca PLC

A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.

Share on Social Networks: